The frequency of the FGF14 GAA≥250 repeat expansion was 2.2% (8/249) among patients with MSA-P, 2.4% (4/166) among patients with MSA-C, and 4.8% (5/104) among patients with MSA-mixed phenotype. Here, FGF14 is linked to multiple system atrophy.